Biocon Biologics

Biocon Biologics is a leading global biosimilars organization, dedicated to transforming healthcare and improving lives through cutting-edge science, innovative tech platforms, and advanced research & development. As a subsidiary of Biocon Limited, Biocon Biologics is committed to lowering treatment costs and improving healthcare outcomes for patients worldwide.

With a robust research pipeline of biosimilar molecules targeting diabetes, oncology, immunology, and other non-communicable diseases, Biocon Biologics is at the forefront of biopharmaceutical innovation. Six molecules from Biocon Biologics’ portfolio have successfully progressed from the laboratory to the market in developed regions, including the United States, EU, Australia, Canada, and Japan. The primary address of Biocon Biologics is Hosur Road, Bengaluru, Karnataka 560100, IN and has other location at 16 GREAT QUEEN STREET.

Driven by a team of approximately 4,800 professionals, Biocon Biologics is focused on enabling affordable access to essential medicines for millions of patients globally. Biocon Biologics continues to expand its reach and impact in the biopharmaceutical landscape, making significant strides in transforming healthcare access. We invite the manager of Biocon Biologics to create a customized and exclusive company showcase and product listing on our platform.